Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Baert

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Gastrointestinal Endoscopy|October 8, 2017
Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitisRaf Bisschops, Talat Bessissow, Evelien Dekker, et al.
Gastroenterology|February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE studyPeter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2014
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitisMaria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|June 2, 2021
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension StudyMarc Ferrante, Brian G Feagan, Julián Panés, et al.
United European Gastroenterology Journal|May 19, 2018
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonistsMartine De Vos, Barbara Dhooghe, Severine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's DiseasePeter Bossuyt, Erwin Dreesen, Jordi Rimola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and DysplasiaAnneline Cremer, Pieter Demetter, Martine De Vos, et al.
International Journal of Colorectal Disease|October 31, 2014
The course of anaemia in children and adolescents with Crohn's disease included in a prospective registryStephanie Van Biervliet, Françoise Smets, Ilse Hofmann, et al.
Journal of Crohn'S & Colitis|January 12, 2024
Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic ReviewCharlotte Wong, Joep van Oostrom, Valerie Pittet, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Gastrointestinal Endoscopy|October 8, 2017
Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitisRaf Bisschops, Talat Bessissow, Evelien Dekker, et al.
Gastroenterology|February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE studyPeter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2014
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitisMaria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|June 2, 2021
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension StudyMarc Ferrante, Brian G Feagan, Julián Panés, et al.
United European Gastroenterology Journal|May 19, 2018
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonistsMartine De Vos, Barbara Dhooghe, Severine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's DiseasePeter Bossuyt, Erwin Dreesen, Jordi Rimola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and DysplasiaAnneline Cremer, Pieter Demetter, Martine De Vos, et al.
International Journal of Colorectal Disease|October 31, 2014
The course of anaemia in children and adolescents with Crohn's disease included in a prospective registryStephanie Van Biervliet, Françoise Smets, Ilse Hofmann, et al.
Journal of Crohn'S & Colitis|January 12, 2024
Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic ReviewCharlotte Wong, Joep van Oostrom, Valerie Pittet, et al.
Pageof 10